Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring Mutation. - Sokolenko, Anna; Preobrazhenskaya, Elena; Marchetti, Claudia; Piermattei, Alessia; Zagrebin, Fedor; Kuligina, Ekatherina; Gorodnova, Tatiana; Pavone, Matteo; Ivantsov, Alexandr; Bizin, Ilya; Scambia, Giovanni; Berlev, Igor; et al. (Pathobiology, 2024)